We are 3-Methoxyacrylic Acid Methyl Ester CAS:34846-90-7 manufacturer and supplier in China, we can offer the best quality and price of 3-Methoxyacrylic Acid Methyl Ester, Pls send inquiry of to email@example.com of visit www.nbinno.com our official website should you have any interests, thank you!
Chemical Name: 3-Methoxyacrylic Acid Methyl Ester
Molecular Formula: C5H8O3
Molecular Weight: 116.11500
Physical and Chemical Properties:
Density: 1.013 g / cm3
Boiling point: 155.3ºC at 760 mmHg
Melting point: 41702ºC
Flash point: 62.8±0.0 °C
Refractive index: 1.417
Appearance: Colorless or light yellow liquid
25kg cardboard drum or according to customer specified requirements
Store at 0-6 ºC.Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Intermediates of Ceftibuten dihydrate CAS:118081-34-8.
Related News: At the same time, due to the increase in production costs and environmental protection cost pressures in Europe and the United States, as well as the improvement of process technology, production quality, and registration and certification capabilities of China’s bulk drug manufacturers, bulk drug companies have accelerated their transfer to China, and the bulk drug industry in China has produced Scale continues to increase.6-Chloro-5-methylpyridin-3-amine “This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment,” Mankind Pharma Director of Marketing Sanjay Koul said in a statement.2,6-Dichloropurine “This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment,” Mankind Pharma Director of Marketing Sanjay Koul said in a statement.9-(2-Bromophenyl)-9H-carbazole The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses.Some experts said that in the research and development of chemical medicine, the possibility of large medicines is getting smaller and smaller, and with the popularization of precision treatment, small medicines (high-efficiency medicines) are being introduced more and more.